Press

Researchers Quantify Cas9-Caused Off-Target Mutagenesis in Mice

Published: Friday, October 18, 2019, 5:35 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan, 301.634.7346, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Scientists are finding new ways to improve the use of the CRISPR enzyme Cas9 and reduce the chances of off-target mutations in laboratory mice, according to new results from... Read More

Researchers Quantify Limitations of Health Reports from Direct-to-Consumer Genetic Tests

Published: Thursday, October 17, 2019, 5:00 p.m. U.S. Central Time Media Contact: Ann Klinck, 301.634.7342, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Health reports from direct-to-consumer (DTC) genetic tests that use a limited variant screening approach often yield clinical false-negative results, which pose the risk of informing health care decisions based... Read More

Cystic Fibrosis Carriers at Increased Risk of Digestive Symptoms

Published: Thursday, October 17, 2019, 12:00 p.m. U.S. Central Time Media Contact: Ann Klinck, 301.634.7342, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis. These findings were... Read More

Researchers Develop Mouse Model of Human Gene Involved in Alzheimer’s Disease

Published: Wednesday, October 16, 2019, 5:30 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan, 301.634.7346, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – In research that helps scientists better understand and explore treatments for diseases like Alzheimer’s, scientists have developed a line of mice in which the mouse version of the Alzheimer’s-associated MAPT gene... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy